Schistosomiasis haematobia: Clinical Trials

6 trials for Schistosomiasis haematobia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 5, Unknown 1
Phase 21Completed 1

Follow Schistosomiasis haematobia: new trials by email Literature Review of Schistosomiasis haematobia trials Research Report on Schistosomiasis haematobia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children
Praziquantel, Artesunate + Mefloquine - Schistosoma Haematobium, Schistosoma Mansoni
Phase 3CompletedInstitute of Tropical Medicine, Belgium7262019-10-142021-04-05
The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium
Companion Tablet - Schistosomiasis Haematobia
Phase 3UnknownJiangsu Institute of Parasitic Diseases1202017-04-102017-04-28
Safety and Efficacy of Mirazid for Schistosomiasis Treatment
Myrrh - Schistosoma Hematobium Infection, Schistosomiasis Mansoni
Phase 3CompletedPharco Pharmaceuticals2002011-12-012015-02-20
Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium
Bilhvax vaccine (Sh28GST), placebo - Urinary Schistosomiasis, Schistosoma Haematobium
Phase 3CompletedInstitut National de la Santé Et de la Recherche Médicale, France2502009-02-012025-12-10
Schistosoma Haematobium Infections and Praziquantel
praziquantel - Schistosomiasis
Phase 3CompletedUniversity of Khartoum5202008-08-012013-01-17
Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis
Artesunate+Sulfamethoxypyrazine/pyrimethamin, Praziquantel - Schistosoma Haematobium
Phase 2 / Phase 3CompletedDafra Pharma8002007-08-012008-01-18

Narrower conditions

Schistosomiasis (2)  ·  Schistosomiasis mansoni (1)

Broader conditions

Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Helminthiasis (6)  ·  Infections (6)  ·  Male Urogenital Diseases (6)  ·  Parasitic Diseases (6)  ·  Trematode Infections (6)  ·  Urinary Tract Infections (6)  ·  Urogenital Diseases (6)  ·  Urologic Diseases (6)  ·  Vector Borne Diseases (6)  ·  Schistosomiasis (4)

Interventions

Praziquantel (4)  ·  Artesunate (1)  ·  Mefloquine (1)  ·  myrrh resin (1)

Sponsors

Dafra Pharma (1)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  Institute of Tropical Medicine, Belgium (1)  ·  Jiangsu Institute of Parasitic Diseases (1)  ·  Pharco Pharmaceuticals (1)  ·  University of Khartoum (1)

Countries

Senegal (2)  ·  Egypt (1)  ·  Mali (1)  ·  Sudan (1)  ·  Tanzania (1)

Top investigators

Ayat A Haggag, MD (1)  ·  Kun Yang, PHD (1)  ·  Mahamadou S Sissoko, MD, MSPH (1)  ·  Moustapha Mbow, MD (1)

Results publications

PMID 19802383, PMID 21729382, PMID 30532268, PMID 30969960, PMID 34168029, PMID 38177851

NIH funding

2008 (1)